Dr. Crotty Alexander is an Associate Professor of Medicine at UCSD, where she directs the first five weeks for the School of Medicine.

She completed her undergraduate and medical education at Duke University prior to Internal Medicine residency at Massachusetts General Hospital. She completed her Pulmonary Critical Care Fellowship training at Harvard, followed by a postdoctoral research fellowship in Pediatric Infectious Disease and Host Defense at the University of California San Diego (UCSD).

Her research focuses on the health effects of e-cigarettes, as well as molecular pathways in asthma and lung inflammation in general.



Dr. Soo Hoo is a Health Sciences Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA and is also the Acting Chief of the Pulmonary, Critical Care and Sleep Section and Director, Medical Intensive Care Unit at the West Los Angeles VA Healthcare Center.

He has been at the VA since 1989 and has a research interest in non-invasive ventilation, as well as non-pharmacologic treatment of Chronic Obstructive Pulmonary Disease (COPD). He is a Board member of BREATHE California of Los Angeles as well as past Chairman of the Board on two occasions.

He has participated in World COPD Day since its inception in 2010. Dr. Soo Hoo has been involved with the care of patients with smoking related conditions during his entire professional career. More recently, he has collaborated on multisite investigations of patients with human immuno-deficiency virus (HIV) infection and effects on COPD and lung cancer.

In addition to academic investigations, he has also been involved with VA wide patient care projects in healthcare delivery, most recently lung cancer screening and comprehensive treatment programs for patients with COPD including pulmonary rehabilitation, advanced bronchoscopic therapies and lung transplantation.


Dr. Casaburi is an Associate Chief for Research in the Division of Respiratory and Critical Care Physiology and Medicine at Harbor-UCLA Medical Center. He is Professor of Medicine at the David Geffen School of Medicine. He occupies the Grancell/Burns Chair in the Rehabilitative Sciences at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center.

He established the Rehabilitation Clinical Trials Center in 1999, a clinical research facility dedicated to improving the lives of COPD patients. Dr. Casaburi has completed more than 75 clinical research studies, including participation in three major NIH multicenter projects. He has published more than 320 papers and 280 abstracts and has presented over 750 invited lectures on the topics of respiratory physiology, exercise science, pulmonary rehabilitation and COPD disease management.

He is a Fellow of the American College of Chest Physicians and the American Association of Cardiovascular and Pulmonary Rehabilitation. He serves as president of the Pulmonary Education and Research Foundation, a non-profit corporation dedicated to advancing the scientific basis and practice of pulmonary rehabilitation and is a member of the Board of Directors of the COPD Foundation and the American Thoracic Society.


Dr. Chaux is Medical Director of the Lung Transplant Program at Cedars-Sinai Medical Center. He is Board Certified in Internal Medicine and has specialized certification in Pulmonary and in Critical Care Medicine. His primary areas of research and clinical interest involve state-of-the-art diagnosis, treatment and post-operative management strategies for lung transplant patients and individuals with pulmonary arterial hypertension and idiopathic pulmonary fibrosis.

In addition, he is actively involved in developing the interventional pulmonology program at Cedars-Sinai Medical Center which includes the advanced use of rigid bronchoscopy with laser treatment of airway tumors, stenting of airway strictures and the introduction of new technologies such as SuperDimension for the biopsy of peripheral lung lesions and endobronchial ultrasound for the biopsy of mediastinal lymph nodes.

He received his bachelor’s degree from Bowdoin College in Brunswick, Maine and his medical degree from Boston University School of Medicine. At the University of California, San Diego Medical Center, he completed an internship and residency in Internal medicine, serving as Chief Resident, and a fellowship in pulmonary and critical care medicine.


Dr. Falk completed medical school at The Ohio State University in 1998, followed by Internal Medicine and chief residency at Temple University in Philadelphia.

He stayed on at Temple to complete his fellowship in pulmonary and critical care medicine in 2005. He joined the faculty at Cedars-Sinai Medical Center in 2006 as the associate director of lung transplant and in 2013 was named fellowship director. He is the medical director of the Cedars-Sinai Alpha One Anti-trypsin Deficiency Program. Dr. Falk’s clinical interests include COPD, alpha one anti-trypsin deficiency, interstitial lung disease and lung transplant.

He has published numerous articles in CHEST, American Journal of Respiratory and Critical Care Medicine, International Journal of Heart and Lung Transplant, and COPD.


Dr. Gelb is board certified in Internal Medicine and Pulmonary Disease in Lakewood, California and is affiliated with multiple hospitals in the area, including Lakewood Regional Medical Center and Los Alamitos Medical Center.

His Academic appoint is Clinical Professor of Medicine, UCLA Medical Center, Geffen School of Medicine, Los Angeles. He received his medical degree from Saint Louis University School of Medicine and has been in practice for more than 20 years.

He is a member of the several societies including American Thoracic Society, Los Angeles County Medical Association and American College Chest Physicians (FCCP).


Dr. Goldin is a Professor of Radiology and Medicine and the Executive Vice Chairman of the Department of Radiological Sciences at the David Geffen School of Medicine at UCLA. He is the Chief of Radiology for the Santa Monica-UCLA Medical Center and Chief of Diagnostic Services at the Martin Luther King Jr. Community Hospital. He is also the Co-Director of the Computer Vision and Imaging Biomarker Group for the Department of Radiological Sciences.

He is a member and fellow of the Royal College of Radiologists (RCR) and a member of the American College of Radiology (ACR). He is a fellow of the Fleischner Society and the International Cancer Imaging Society (ICIS).

He trained at the University of Cape Town Medical School, South Africa, obtaining his medical degree in 1983 and completed his internship at Groote Schuur Hospital in 1986. He completed his PhD, at University of Cape Town, Faculty of Medicine in 1990, followed by residency in Diagnostic Radiology in 1994 at the St. Bartholomew’s Hospital in London, England, and a fellowship in Thoracic Radiology at UCLA.


Dr. Ronald B. Natale is currently a Professor of Medicine in the Division of Medical Oncology and Director of the Lung Cancer Clinical Research Program in the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center.

He has had over 30 years of experience as a medical oncology physician-scientist with a major interest in lung cancer basic and translational clinical research and over 200 peer-reviewed publications.

He co-developed the platinum-etoposide chemotherapy regimen that has been the world-wide standard of care for the treatment of small cell lung cancer for over 25 years. He developed the carboplatin + paclitaxel regimen that was the primary chemotherapy regimen for the treatment of non-small cell lung cancer.

In addition, he has been one of the leading investigators in the development of new treatments targeting specific driver mutations in lung cancer and in the development of novel immunotherapies.


Dr. Noble is a physician scientist with an active research laboratory focused on elucidating the basic mechanisms of lung fibrosis.

His research laboratory has been funded by the National Institutes of Health since 1992. Dr. Noble has been involved in industry-sponsored clinical trials evaluating new therapies in IPF and participated in both the pirfenidone and nintedanib programs that led to the first FDA approved treatments for IPF. He continues to have an active clinical practice in ILD.
Paul W. Noble, MD, received his Bachelor of Arts degree from Haverford College in Pennsylvania, and his medical degree from New York University School of Medicine. He completed his medical residency and chief residency at the University of California, San Francisco Hospitals. He completed his pulmonary and critical care fellowships at the University of Colorado and the National Jewish Center in Denver, Colorado.

He is an elected member of the American Society of Clinical Investigation and the American Association of Physicians. He is a Deputy Editor of the Journal of Clinical Investigation.


Dr. Tiep is a seasoned pulmonologist who is distinguished amongst his peers and associates and has been the recipient of many prestigious awards and recognition throughout his celebrated career as a physician.

He is the author of an immense body of peer reviewed original abstracts, articles, reviews and contributions in the area of pulmonary medicine. He has served on the editorial boards of respiratory journals and has presented various topics at scientific conferences, nationally and internationally. He has developed several patents in the area of oxygen therapy and developed the Respiratory Disease Management InStitute and Pulmonary Rehabilitation programs that support the treatment and management of patients from post-acute care through end-of-life at City of Hope Medical Center.

He has participated in leadership roles with many organizations and is well versed on the diagnosis, treatment and management of patients throughout the continuum of care.